YOLFTbeta
Star Combo Pharma Ltd

Star Combo Pharma Ltd

S66 · AU · Consumer Defensive / Household & Personal Products

0.14AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.14
Open0.14
Day Range0.14 – 0.14
52-Week Range0.11 – 0.275
Volume71
Market Cap18.91M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield2.11%
Beta0.35
50-Day Avg0.1351
200-Day Avg0.1783

About

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMs. Su Zhang M.B.A.
  • Employees0
  • Headquarters171-177 Woodpark Road, Smithfield, NSW, Australia, 2164, Australia
  • Websitehttps://www.starcombo.com.au

Leadership

  • Ms. Su Zhang M.B.A.CEO & Executive Director
  • Mr. JinXing Zhang B.S.Founder, MD & Director
  • Mr. James NiChief Financial Officer
  • He Ben B.S.Chief Operating Officer
  • Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPACompany Secretary

Financials

Income Statement

Currency: AUD2014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue5.06M6.70M9.35M9.79M10.75M21.41M38.84M26.72M22.88M24.70M26.02M27.81M23.57M
Growth (%)-+32.37%+39.56%+4.63%+9.84%+99.17%+81.39%-31.18%-14.38%+7.95%+5.34%+6.89%-15.24%
Cost of Revenue3.64M5.28M4.94M5.85M6.17M17.73M33.55M22.12M17.27M17.54M20.58M21.54M18.58M
Gross Profit1.42M1.42M4.41M3.94M4.58M3.68M5.29M4.61M5.61M4.66M5.44M6.27M4.99M
Gross Margin28.12%21.19%47.16%40.25%42.62%17.17%13.62%17.25%24.51%18.85%20.90%22.55%21.17%
Operating Expense843.34K1.09M1.08M1.36M6.65M5.99M5.80M6.83M6.05M3.69M4.72M6.51M5.22M
Operating Income580.67K331.94K3.33M2.58M-2.07M-2.31M-512.54K-2.23M-445.59K961.78K723.43K-237.98K-231.10K
Operating Margin11.47%4.95%35.63%26.35%-19.24%-10.80%-1.32%-8.33%-1.95%3.89%2.78%-0.86%-0.98%
EBITDA591.39K348.20K3.57M2.72M-1.46M-1.93M352.23K-6.40M-126.71K-2.53M2.79M6.64M1.24M
EBITDA Margin11.68%5.20%38.21%27.75%-13.62%-9.03%0.91%-23.93%-0.55%-10.23%10.71%23.86%5.28%
Net Income407.31K236.44K1.82M1.64M-1.97M-1.73M-348.69K-7.88M-696.35K-4.00M747.33K5.25M394.61K
Net Income Margin8.04%3.53%19.45%16.71%-18.36%-8.07%-0.90%-29.47%-3.04%-16.21%2.87%18.87%1.67%
R&D-----48.91K146.72K146.72K146.72K----
R&D as % of Total Revenue-----0.23%0.38%0.55%0.64%----
Interest Expense-082.22K105.68K104.16K26.62K393.87K235.72K171.47K186.87K196.13K191.93K201.24K
Interest Expense % of Total Revenue-0.00%0.88%1.08%0.97%0.12%1.01%0.88%0.75%0.76%0.75%0.69%0.85%

Balance Sheet

Currency: AUD2016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets7.09M19.32M19.03M27.51M54.72M43.32M43.44M42.23M42.82M48.45M50.11M
Total Liabilities3.21M3.64M2.78M7.51M10.22M7.13M8.04M8.97M9.30M10.19M11.28M
Total Equity3.88M15.68M16.26M20.00M44.50M36.19M35.41M33.09M33.32M38.08M38.83M
Cash159.94K10.21M8.94M4.62M26.60M17.32M4.39M2.99M2.16M3.59M3.91M
Total Debt1.25M1.62M135.55K57.86K5.61M3.30M4.12M4.19M4.03M3.93M4.19M
Net Debt1.09M-8.59M-8.81M-4.57M-20.99M-14.03M-6.27M-5.30M1.86M340.99K284.18K

Cash Flow

Currency: AUD2014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--308.65K1.30M932.20K-1.84M-2.19M-1.02M331.53K87.11K1.88M-316.45K11.94M3.28M
Investing Cash Flow--1.31M-1.15M-261.13K-813.31K-3.92M-3.63M-7.53M-3.24M-3.23M-136.79K-9.72M-2.02M
Financing Cash Flow-1.31M-108.24K5.37M5.39M1.79M26.63M-2.08M-169.08K-53.44K-370.93K-795.12K-940.75K
Capital Expenditure01.31M1.15M261.13K198.72K4.24M2.78M7.26M7.29M2.73M1.44M393.72K2.45M
Free Cash Flow--149.62K671.07K-2.04M-6.42M-3.80M-6.93M-7.21M-851.83K-1.76M11.55M822.64K
Dividends Paid-45.50K----2.06M----500.00K500.00K
FCF to OCF--11.54%71.99%110.81%293.97%373.25%-2089.06%-8273.96%-45.39%555.61%96.70%25.11%
Dividend Paid to FCF-------54.27%----4.33%60.78%

Earnings

Report DateFeb 3, 2017Aug 4, 2017May 14, 2018Aug 31, 2018Feb 28, 2019Aug 28, 2019Feb 26, 2020Aug 25, 2020Feb 23, 2021Aug 24, 2021Feb 23, 2022Aug 23, 2022Feb 23, 2023Feb 26, 2025Aug 18, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.00-0.00--0.00-
EPS Actual0.010.010.01-0.05-0.020.00-0.020.010.00-0.060.00-0.01-0.030.000.03
Surprise---------------
Timing-----------Pre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap18.91M
Enterprise Value5.09M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.80
Price / Book0.49
EPS0.00
Book Value0.287
Revenue (TTM)23.57M
Gross Profit (TTM)5.78M
EBITDA1.22M
Profit Margin1.67%
Operating Margin-1.34%
Return on Equity1.02%
Return on Assets0.01%
Shares Outstanding135.08M
Shares Float11.82M
Beta0.35
Dividend Yield2.11%
Dividend Rate0.00
Payout Ratio9.28%

Dividends

20261×
0.00Oct 13, 2026
20251×
0.00Oct 14, 2025
20241×
0.00Oct 14, 2024